Action 300601 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shenzhen Kangtai Biological Products Co., Ltd.

Actions

300601

CNE100002Q33

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 29/04/2024 		Varia. 5j. Varia. 1 janv.
20,37 CNY -1,83% Graphique intraday de Shenzhen Kangtai Biological Products Co., Ltd. +2,16% -24,97%
26/04 Shenzhen Kangtai Biological Products Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
26/04 Shenzhen Kangtai Biological Products Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Kangtai Biological Forecasts Swing to Profit in 2023
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemented (A Shares) for 2023, Payable on 13 October 2023
Shenzhen Kangtai Biological Products Co., Ltd. Approves 2023 Interim Cash Dividend
Kangtai Signs Deal to Distribute Varicella Vaccine in Pakistan, India
Shenzhen Kangtai Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Kangtai Biological Partners With Indian Drugmaker to Distribute Pneumococcal Vaccine
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback announced on October 12, 2022 has closed with 3,581,600 shares, representing 0.32% for CNY 120.97 million.
Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
Shares in Chinese Pharma Companies Decline Amid Drop in Vaccination Rates
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
Shenzhen Kangtai Biological Products Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 14, 2022.
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300601
  4. Actualités Shenzhen Kangtai Biological Products Co., Ltd.
  5. Autres langues